Entrada Therapeutics, Inc.
NASDAQ:TRDA
15 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2020 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||
| Current Assets: | ||||||||||||||
| Cash & Cash Equivalents
| 185.253 | 68.436 | 67.602 | 51.882 | 376.789 | 227.648 | 45.157 | 53.311 | 90.867 | 84.64 | 291.064 | 122.172 | 136.947 | 39.045 |
| Short Term Investments
| 284.493 | 258.978 | 284.367 | 301.696 | 297.046 | 183.983 | 143.555 | 162.261 | 153.387 | 179.262 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 469.746 | 327.414 | 351.969 | 353.578 | 376.789 | 227.648 | 45.157 | 215.572 | 244.254 | 263.902 | 291.064 | 122.172 | 136.947 | 39.045 |
| Net Receivables
| 9.074 | 77.514 | 7.578 | 5.025 | 3.744 | 6.297 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | -5.025 | 0 | 183.983 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 10.716 | 9.244 | 10.224 | 29.465 | 9.662 | 16.207 | 21.163 | 19.161 | 9.649 | 8.81 | 7.636 | 1.353 | 0.689 | 0.904 |
| Total Current Assets
| 489.536 | 414.172 | 369.771 | 383.043 | 390.195 | 434.135 | 209.875 | 234.733 | 253.903 | 272.712 | 298.7 | 123.525 | 137.636 | 39.949 |
| Non-Current Assets: | ||||||||||||||
| Property, Plant & Equipment, Net
| 87.73 | 89.96 | 92.681 | 95.059 | 99.3 | 23.641 | 33.021 | 34.826 | 37.189 | 38.606 | 6.261 | 5.901 | 5.087 | 3.037 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.747 | 2.762 | 2.79 | 2.981 | 0.538 | 13.843 | 5.21 | 0.954 | 0.875 | 5.384 | 0.872 | 2.969 | 0.791 | 0.541 |
| Total Non-Current Assets
| 92.427 | 96.672 | 99.421 | 101.99 | 103.788 | 41.434 | 42.181 | 39.73 | 42.014 | 43.99 | 7.133 | 8.87 | 5.878 | 3.578 |
| Total Assets
| 581.963 | 510.844 | 469.192 | 485.033 | 493.983 | 475.569 | 252.056 | 274.463 | 295.917 | 316.702 | 305.833 | 132.395 | 143.514 | 43.527 |
| Liabilities & Equity: | ||||||||||||||
| Current Liabilities: | ||||||||||||||
| Account Payables
| 1.635 | 2.527 | 3.277 | 0.752 | 2.422 | 6.474 | 5.99 | 1.341 | 4.622 | 2.931 | 0.706 | 2.278 | 1.881 | 1.602 |
| Short Term Debt
| 8.567 | 8.301 | 7.909 | 6.642 | 7.409 | 7.103 | 8.406 | 8.259 | 8.114 | 7.971 | 0 | 0 | 0 | 0 |
| Tax Payables
| 4.111 | 5.855 | 4.024 | 0 | 7.359 | 3.551 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 60.497 | 148.463 | 132.261 | 148.44 | 101.645 | 122.341 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 15.11 | 14.647 | 15.349 | 9.599 | 14.464 | 11.676 | 7.576 | 11.951 | 5.341 | 4.524 | 6.013 | 4.88 | 2.655 | 1.757 |
| Total Current Liabilities
| 85.809 | 173.938 | 158.796 | 165.433 | 125.94 | 147.594 | 21.972 | 21.551 | 18.077 | 15.426 | 6.719 | 7.158 | 4.536 | 3.359 |
| Non-Current Liabilities: | ||||||||||||||
| Long Term Debt
| 55.876 | 58.131 | 60.321 | 62.431 | 65.624 | 9.122 | 17.53 | 19.692 | 21.801 | 23.885 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 10.353 | 9.408 | 7.715 | 10.506 | 95.511 | 89.241 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | -9.408 | -60.321 | -10.506 | -95.511 | -89.241 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 9.408 | 60.321 | 10.506 | 95.511 | 89.241 | 0 | 0 | 0 | 0 | 0.396 | 197.828 | 197.992 | 81.658 |
| Total Non-Current Liabilities
| 66.229 | 67.539 | 68.036 | 72.937 | 161.135 | 98.363 | 17.53 | 19.692 | 21.801 | 23.885 | 0.396 | 197.828 | 197.992 | 81.658 |
| Total Liabilities
| 152.038 | 241.477 | 226.832 | 238.37 | 287.075 | 245.957 | 39.502 | 41.243 | 39.878 | 39.311 | 7.115 | 204.986 | 202.528 | 85.017 |
| Equity: | ||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197.489 | 0 | 0 |
| Common Stock
| 0.004 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0 | 0 |
| Retained Earnings
| -116.443 | -171.474 | -194.97 | -185.426 | -220.887 | -194.959 | -188.285 | -163.656 | -138.519 | -115.34 | -93.669 | -75.222 | -60.792 | -42.511 |
| Accumulated Other Comprehensive Income/Loss
| -0.329 | -0.246 | 0.195 | -0.496 | -1.005 | -0.642 | -2.057 | -2.747 | -2.265 | -1.535 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 546.693 | 441.084 | 437.132 | 432.582 | 428.797 | 425.21 | 402.893 | 399.62 | 396.82 | 394.263 | 392.384 | -194.858 | 1.778 | 1.021 |
| Total Shareholders Equity
| 429.925 | 269.367 | 242.36 | 246.663 | 206.908 | 229.612 | 212.554 | 233.22 | 256.039 | 277.391 | 298.718 | -72.591 | -59.014 | -41.49 |
| Total Equity
| 429.925 | 269.367 | 242.36 | 246.663 | 206.908 | 229.612 | 212.554 | 233.22 | 256.039 | 277.391 | 298.718 | -72.591 | -59.014 | -41.49 |
| Total Liabilities & Shareholders Equity
| 581.963 | 510.844 | 469.192 | 485.033 | 493.983 | 475.569 | 252.056 | 274.463 | 295.917 | 316.702 | 305.833 | 132.395 | 143.514 | 43.527 |